#begin document wsj_1934
1	A	a	_	DT	_	_	_	3	_	AuxA	_	_	_	_	_	EnglishA-wsj_1934-s1-t1	(3
2	new	new	_	JJ	_	_	_	3	_	Atr	_	_	_	_	_	EnglishA-wsj_1934-s1-t2	_
3	drug	drug	_	NN	_	_	_	14	_	Sb	_	_	_	_	_	EnglishA-wsj_1934-s1-t3	3)
4	to	to	_	TO	_	_	_	3	_	AuxP	_	_	_	_	_	EnglishA-wsj_1934-s1-t6	_
5	prevent	prevent	_	VB	_	_	_	4	_	Atr	_	_	_	_	_	EnglishA-wsj_1934-s1-t7	_
6	the	the	_	DT	_	_	_	7	_	AuxA	_	_	_	_	_	EnglishA-wsj_1934-s1-t8	_
7	rejection	rejection	_	NN	_	_	_	5	_	Obj	_	_	_	_	_	EnglishA-wsj_1934-s1-t9	_
8	of	of	_	IN	_	_	_	7	_	AuxP	_	_	_	_	_	EnglishA-wsj_1934-s1-t10	_
9	transplanted	transplanted	_	JJ	_	_	_	10	_	Atr	_	_	_	_	_	EnglishA-wsj_1934-s1-t11	_
10	organs	organ	_	NNS	_	_	_	8	_	Atr	_	_	_	_	_	EnglishA-wsj_1934-s1-t12	_
11	has	have	_	VBZ	_	_	_	14	_	AuxV	_	_	_	_	_	EnglishA-wsj_1934-s1-t13	_
12	been	be	_	VBN	_	_	_	14	_	AuxV	_	_	_	_	_	EnglishA-wsj_1934-s1-t14	_
13	successfully	successfully	_	RB	_	_	_	14	_	Adv	_	_	_	_	_	EnglishA-wsj_1934-s1-t15	_
14	used	use	_	VBN	_	_	_	0	_	Pred	_	_	_	_	_	EnglishA-wsj_1934-s1-t16	_
15	on	on	_	IN	_	_	_	14	_	AuxP	_	_	_	_	_	EnglishA-wsj_1934-s1-t18	_
16	more	more	_	JJR	_	_	_	17	_	NR	_	_	_	_	_	EnglishA-wsj_1934-s1-t19	(1
17	than	than	_	IN	_	_	_	19	_	AuxP	_	_	_	_	_	EnglishA-wsj_1934-s1-t20	_
18	100	100	_	CD	_	_	_	17	_	Atr	_	_	_	_	_	EnglishA-wsj_1934-s1-t21	_
19	patients	patient	_	NNS	_	_	_	15	_	Adv	_	_	_	_	_	EnglishA-wsj_1934-s1-t22	1)
20	at	at	_	IN	_	_	_	14	_	AuxP	_	_	_	_	_	EnglishA-wsj_1934-s1-t23	_
21	the	the	_	DT	_	_	_	22	_	AuxA	_	_	_	_	_	EnglishA-wsj_1934-s1-t24	(2
22	University	university	_	NNP	_	_	_	20	_	Adv	_	_	_	_	_	EnglishA-wsj_1934-s1-t25	_
23	of	of	_	IN	_	_	_	22	_	AuxP	_	_	_	_	_	EnglishA-wsj_1934-s1-t26	_
24	Pittsburgh	pittsburgh	_	NNP	_	_	_	23	_	Atr	_	_	_	_	_	EnglishA-wsj_1934-s1-t27	2)
25	,	,	_	,	_	_	_	14	_	AuxX	_	_	_	_	_	EnglishA-wsj_1934-s1-t28	_
26	according	accord	_	VBG	_	_	_	14	_	Adv	_	_	_	_	_	EnglishA-wsj_1934-s1-t29	_
27	to	to	_	TO	_	_	_	26	_	AuxP	_	_	_	_	_	EnglishA-wsj_1934-s1-t30	_
28	researchers	researcher	_	NNS	_	_	_	27	_	Adv	_	_	_	_	_	EnglishA-wsj_1934-s1-t31	_
29	.	.	_	.	_	_	_	14	_	AuxG	_	_	_	_	_	EnglishA-wsj_1934-s1-t32	_

30	The	the	_	DT	_	_	_	31	_	AuxA	_	_	_	_	_	EnglishA-wsj_1934-s2-t1	(3
31	drug	drug	_	NN	_	_	_	44	_	Sb	_	_	_	_	_	EnglishA-wsj_1934-s2-t2	_
32	,	,	_	,	_	_	_	31	_	AuxX	_	_	_	_	_	EnglishA-wsj_1934-s2-t3	3)
33	which	which	_	WDT	_	_	_	34	_	Sb	_	_	_	_	_	EnglishA-wsj_1934-s2-t4	(3)
34	is	be	_	VBZ	_	_	_	31	_	Atr	_	_	_	_	_	EnglishA-wsj_1934-s2-t6	_
35	still	still	_	RB	_	_	_	34	_	Adv	_	_	_	_	_	EnglishA-wsj_1934-s2-t7	_
36	in	in	_	IN	_	_	_	34	_	AuxP	_	_	_	_	_	EnglishA-wsj_1934-s2-t8	_
37	the	the	_	DT	_	_	_	39	_	AuxA	_	_	_	_	_	EnglishA-wsj_1934-s2-t9	_
38	experimental	experimental	_	JJ	_	_	_	39	_	Atr	_	_	_	_	_	EnglishA-wsj_1934-s2-t10	_
39	phase	phase	_	NN	_	_	_	36	_	Adv	_	_	_	_	_	EnglishA-wsj_1934-s2-t11	_
40	,	,	_	,	_	_	_	31	_	AuxX	_	_	_	_	_	EnglishA-wsj_1934-s2-t12	_
41	has	have	_	VBZ	_	_	_	44	_	AuxV	_	_	_	_	_	EnglishA-wsj_1934-s2-t13	_
42	n't	n't	_	RB	_	_	_	44	_	Adv	_	_	_	_	_	EnglishA-wsj_1934-s2-t14	_
43	been	be	_	VBN	_	_	_	44	_	AuxV	_	_	_	_	_	EnglishA-wsj_1934-s2-t15	_
44	approved	approve	_	VBN	_	_	_	53	_	Pred	_	_	_	_	_	EnglishA-wsj_1934-s2-t16	_
45	yet	yet	_	RB	_	_	_	44	_	Adv	_	_	_	_	_	EnglishA-wsj_1934-s2-t18	_
46	by	by	_	IN	_	_	_	44	_	AuxP	_	_	_	_	_	EnglishA-wsj_1934-s2-t19	_
47	the	the	_	DT	_	_	_	51	_	AuxA	_	_	_	_	_	EnglishA-wsj_1934-s2-t20	(9
48	Food	food	_	NNP	_	_	_	49	_	Atr	_	_	_	_	_	EnglishA-wsj_1934-s2-t21	_
49	and	and	_	CC	_	_	_	51	_	Coord	_	_	_	_	_	EnglishA-wsj_1934-s2-t22	_
50	Drug	drug	_	NNP	_	_	_	49	_	Atr	_	_	_	_	_	EnglishA-wsj_1934-s2-t23	_
51	Admistration	admistration	_	NNP	_	_	_	46	_	Adv	_	_	_	_	_	EnglishA-wsj_1934-s2-t24	9)
52	,	,	_	,	_	_	_	53	_	ExD	_	_	_	_	_	EnglishA-wsj_1934-s2-t25	_
53	and	and	_	CC	_	_	_	0	_	Coord	_	_	_	_	_	EnglishA-wsj_1934-s2-t26	_
54	its	its	_	PRP$	_	_	_	56	_	Atr	_	_	_	_	_	EnglishA-wsj_1934-s2-t27	(3)
55	long-term	long-term	_	JJ	_	_	_	56	_	Atr	_	_	_	_	_	EnglishA-wsj_1934-s2-t28	_
56	effects	effect	_	NNS	_	_	_	57	_	Sb	_	_	_	_	_	EnglishA-wsj_1934-s2-t29	_
57	are	be	_	VBP	_	_	_	53	_	Pred	_	_	_	_	_	EnglishA-wsj_1934-s2-t30	_
58	unknown	known	_	JJ	_	_	_	57	_	Pnom	_	_	_	_	_	EnglishA-wsj_1934-s2-t31	_
59	.	.	_	.	_	_	_	53	_	AuxG	_	_	_	_	_	EnglishA-wsj_1934-s2-t32	_

60	But	but	_	CC	_	_	_	62	_	NR	_	_	_	_	_	EnglishA-wsj_1934-s3-t1	_
61	researchers	researcher	_	NNS	_	_	_	62	_	Sb	_	_	_	_	_	EnglishA-wsj_1934-s3-t2	_
62	say	say	_	VBP	_	_	_	69	_	Pred	_	_	_	_	_	EnglishA-wsj_1934-s3-t3	_
63	the	the	_	DT	_	_	_	64	_	AuxA	_	_	_	_	_	EnglishA-wsj_1934-s3-t5	(3
64	drug	drug	_	NN	_	_	_	69	_	Sb	_	_	_	_	_	EnglishA-wsj_1934-s3-t6	3)
65	,	,	_	,	_	_	_	64	_	AuxX	_	_	_	_	_	EnglishA-wsj_1934-s3-t7	_
66	called	call	_	VBN	_	_	_	64	_	Atr	_	_	_	_	_	EnglishA-wsj_1934-s3-t8	_
67	FK-506	fk-506	_	NNP	_	_	_	66	_	Obj	_	_	_	_	_	EnglishA-wsj_1934-s3-t10	_
68	,	,	_	,	_	_	_	64	_	AuxX	_	_	_	_	_	EnglishA-wsj_1934-s3-t11	_
69	could	could	_	MD	_	_	_	0	_	Adv	_	_	_	_	_	EnglishA-wsj_1934-s3-t12	_
70	revolutionize	revolutionize	_	VB	_	_	_	69	_	Obj	_	_	_	_	_	EnglishA-wsj_1934-s3-t13	_
71	the	the	_	DT	_	_	_	73	_	AuxA	_	_	_	_	_	EnglishA-wsj_1934-s3-t14	_
72	transplantation	transplantation	_	NN	_	_	_	73	_	Atr	_	_	_	_	_	EnglishA-wsj_1934-s3-t15	_
73	field	field	_	NN	_	_	_	70	_	Obj	_	_	_	_	_	EnglishA-wsj_1934-s3-t16	_
74	by	by	_	IN	_	_	_	79	_	AuxC	_	_	_	_	_	EnglishA-wsj_1934-s3-t17	_
75	reducing	reduce	_	VBG	_	_	_	74	_	NR	_	_	_	_	_	EnglishA-wsj_1934-s3-t19	_
76	harmful	harmful	_	JJ	_	_	_	78	_	Atr	_	_	_	_	_	EnglishA-wsj_1934-s3-t20	_
77	side	side	_	JJ	_	_	_	78	_	Atr	_	_	_	_	_	EnglishA-wsj_1934-s3-t21	_
78	effects	effect	_	NNS	_	_	_	75	_	Obj	_	_	_	_	_	EnglishA-wsj_1934-s3-t22	_
79	and	and	_	CC	_	_	_	70	_	Coord	_	_	_	_	_	EnglishA-wsj_1934-s3-t23	_
80	by	by	_	IN	_	_	_	79	_	AuxC	_	_	_	_	_	EnglishA-wsj_1934-s3-t24	_
81	lowering	lower	_	VBG	_	_	_	80	_	NR	_	_	_	_	_	EnglishA-wsj_1934-s3-t26	_
82	rejection	rejection	_	NN	_	_	_	83	_	Atr	_	_	_	_	_	EnglishA-wsj_1934-s3-t27	_
83	rates	rate	_	NNS	_	_	_	81	_	Obj	_	_	_	_	_	EnglishA-wsj_1934-s3-t28	_
84	.	.	_	.	_	_	_	69	_	AuxG	_	_	_	_	_	EnglishA-wsj_1934-s3-t29	_

85	Rejection	rejection	_	NN	_	_	_	87	_	Sb	_	_	_	_	_	EnglishA-wsj_1934-s4-t1	_
86	has	have	_	VBZ	_	_	_	87	_	AuxV	_	_	_	_	_	EnglishA-wsj_1934-s4-t2	_
87	been	be	_	VBN	_	_	_	0	_	Pred	_	_	_	_	_	EnglishA-wsj_1934-s4-t3	_
88	the	the	_	DT	_	_	_	90	_	AuxA	_	_	_	_	_	EnglishA-wsj_1934-s4-t4	_
89	major	major	_	JJ	_	_	_	90	_	Atr	_	_	_	_	_	EnglishA-wsj_1934-s4-t5	_
90	obstacle	obstacle	_	NN	_	_	_	87	_	Pnom	_	_	_	_	_	EnglishA-wsj_1934-s4-t6	_
91	in	in	_	IN	_	_	_	87	_	AuxP	_	_	_	_	_	EnglishA-wsj_1934-s4-t7	_
92	the	the	_	DT	_	_	_	96	_	AuxA	_	_	_	_	_	EnglishA-wsj_1934-s4-t8	(19
93	approximately	approximately	_	RB	_	_	_	94	_	Atr	_	_	_	_	_	EnglishA-wsj_1934-s4-t9	_
94	30,000	30,000	_	CD	_	_	_	96	_	Atr	_	_	_	_	_	EnglishA-wsj_1934-s4-t10	_
95	organ	organ	_	NN	_	_	_	96	_	Atr	_	_	_	_	_	EnglishA-wsj_1934-s4-t11	_
96	transplants	transplant	_	NNS	_	_	_	91	_	Adv	_	_	_	_	_	EnglishA-wsj_1934-s4-t12	19)
97	performed	perform	_	VBN	_	_	_	96	_	Atr	_	_	_	_	_	EnglishA-wsj_1934-s4-t13	_
98	world-wide	world-wide	_	RB	_	_	_	97	_	Adv	_	_	_	_	_	EnglishA-wsj_1934-s4-t15	_
99	each	each	_	DT	_	_	_	100	_	Atr	_	_	_	_	_	EnglishA-wsj_1934-s4-t16	_
100	year	year	_	NN	_	_	_	97	_	Adv	_	_	_	_	_	EnglishA-wsj_1934-s4-t17	_
101	.	.	_	.	_	_	_	87	_	AuxG	_	_	_	_	_	EnglishA-wsj_1934-s4-t18	_

102	Researchers	researcher	_	NNS	_	_	_	103	_	Sb	_	_	_	_	_	EnglishA-wsj_1934-s5-t1	(20)
103	began	begin	_	VBD	_	_	_	0	_	Pred	_	_	_	_	_	EnglishA-wsj_1934-s5-t2	_
104	using	use	_	VBG	_	_	_	103	_	Adv	_	_	_	_	_	EnglishA-wsj_1934-s5-t4	_
105	the	the	_	DT	_	_	_	106	_	AuxA	_	_	_	_	_	EnglishA-wsj_1934-s5-t5	(3
106	drug	drug	_	NN	_	_	_	104	_	Obj	_	_	_	_	_	EnglishA-wsj_1934-s5-t6	3)
107	in	in	_	IN	_	_	_	103	_	AuxP	_	_	_	_	_	EnglishA-wsj_1934-s5-t8	_
108	February	february	_	NNP	_	_	_	107	_	Adv	_	_	_	_	_	EnglishA-wsj_1934-s5-t9	_
109	on	on	_	IN	_	_	_	103	_	AuxP	_	_	_	_	_	EnglishA-wsj_1934-s5-t10	_
110	patients	patient	_	NNS	_	_	_	109	_	Adv	_	_	_	_	_	EnglishA-wsj_1934-s5-t11	(21)
111	who	who	_	WP	_	_	_	113	_	Sb	_	_	_	_	_	EnglishA-wsj_1934-s5-t12	(21)
112	had	have	_	VBD	_	_	_	113	_	AuxV	_	_	_	_	_	EnglishA-wsj_1934-s5-t14	_
113	received	receive	_	VBN	_	_	_	110	_	Atr	_	_	_	_	_	EnglishA-wsj_1934-s5-t15	_
114	kidney	kidney	_	NN	_	_	_	119	_	Atr	_	_	_	_	_	EnglishA-wsj_1934-s5-t16	_
115	,	,	_	,	_	_	_	119	_	AuxX	_	_	_	_	_	EnglishA-wsj_1934-s5-t17	_
116	liver	liver	_	NN	_	_	_	119	_	Atr	_	_	_	_	_	EnglishA-wsj_1934-s5-t18	_
117	,	,	_	,	_	_	_	119	_	AuxX	_	_	_	_	_	EnglishA-wsj_1934-s5-t19	_
118	heart	heart	_	NN	_	_	_	119	_	Atr	_	_	_	_	_	EnglishA-wsj_1934-s5-t20	_
119	and	and	_	CC	_	_	_	121	_	Coord	_	_	_	_	_	EnglishA-wsj_1934-s5-t21	_
120	pancreas	pancreas	_	NN	_	_	_	119	_	Atr	_	_	_	_	_	EnglishA-wsj_1934-s5-t22	_
121	transplants	transplant	_	NNS	_	_	_	113	_	Obj	_	_	_	_	_	EnglishA-wsj_1934-s5-t23	_
122	.	.	_	.	_	_	_	103	_	AuxG	_	_	_	_	_	EnglishA-wsj_1934-s5-t24	_

123	Only	only	_	RB	_	_	_	125	_	Adv	_	_	_	_	_	EnglishA-wsj_1934-s6-t1	_
124	two	two	_	CD	_	_	_	125	_	Atr	_	_	_	_	_	EnglishA-wsj_1934-s6-t2	_
125	of	of	_	IN	_	_	_	127	_	AuxP	_	_	_	_	_	EnglishA-wsj_1934-s6-t3	_
126	111	111	_	CD	_	_	_	125	_	Atr	_	_	_	_	_	EnglishA-wsj_1934-s6-t4	_
127	transplants	transplant	_	NNS	_	_	_	130	_	Sb	_	_	_	_	_	EnglishA-wsj_1934-s6-t5	_
128	have	have	_	VBP	_	_	_	130	_	AuxV	_	_	_	_	_	EnglishA-wsj_1934-s6-t6	_
129	been	be	_	VBN	_	_	_	130	_	AuxV	_	_	_	_	_	EnglishA-wsj_1934-s6-t7	_
130	rejected	reject	_	VBN	_	_	_	0	_	Pred	_	_	_	_	_	EnglishA-wsj_1934-s6-t8	_
131	.	.	_	.	_	_	_	130	_	AuxG	_	_	_	_	_	EnglishA-wsj_1934-s6-t10	_

132	The	the	_	DT	_	_	_	133	_	AuxA	_	_	_	_	_	EnglishA-wsj_1934-s7-t1	(3
133	drug	drug	_	NN	_	_	_	140	_	Sb	_	_	_	_	_	EnglishA-wsj_1934-s7-t2	3)
134	,	,	_	,	_	_	_	133	_	AuxX	_	_	_	_	_	EnglishA-wsj_1934-s7-t3	_
135	discovered	discover	_	VBN	_	_	_	133	_	Atr	_	_	_	_	_	EnglishA-wsj_1934-s7-t4	_
136	in	in	_	IN	_	_	_	135	_	AuxP	_	_	_	_	_	EnglishA-wsj_1934-s7-t6	_
137	1984	1984	_	CD	_	_	_	136	_	Adv	_	_	_	_	_	EnglishA-wsj_1934-s7-t7	_
138	,	,	_	,	_	_	_	133	_	AuxX	_	_	_	_	_	EnglishA-wsj_1934-s7-t8	_
139	is	be	_	VBZ	_	_	_	140	_	AuxV	_	_	_	_	_	EnglishA-wsj_1934-s7-t9	_
140	metabolized	metabolize	_	VBN	_	_	_	0	_	Pred	_	_	_	_	_	EnglishA-wsj_1934-s7-t10	_
141	from	from	_	IN	_	_	_	140	_	AuxP	_	_	_	_	_	EnglishA-wsj_1934-s7-t12	_
142	soil	soil	_	NN	_	_	_	143	_	Atr	_	_	_	_	_	EnglishA-wsj_1934-s7-t13	(22
143	fungus	fungus	_	NN	_	_	_	141	_	Adv	_	_	_	_	_	EnglishA-wsj_1934-s7-t14	22)
144	found	find	_	VBN	_	_	_	143	_	Atr	_	_	_	_	_	EnglishA-wsj_1934-s7-t15	_
145	in	in	_	IN	_	_	_	144	_	AuxP	_	_	_	_	_	EnglishA-wsj_1934-s7-t17	_
146	Japan	japan	_	NNP	_	_	_	145	_	Adv	_	_	_	_	_	EnglishA-wsj_1934-s7-t18	_
147	.	.	_	.	_	_	_	140	_	AuxG	_	_	_	_	_	EnglishA-wsj_1934-s7-t19	_

148	The	the	_	DT	_	_	_	150	_	AuxA	_	_	_	_	_	EnglishA-wsj_1934-s8-t1	(1
149	Pittsburgh	pittsburgh	_	NNP	_	_	_	150	_	Atr	_	_	_	_	_	EnglishA-wsj_1934-s8-t2	(2)
150	patients	patient	_	NNS	_	_	_	151	_	Sb	_	_	_	_	_	EnglishA-wsj_1934-s8-t3	1)
151	are	be	_	VBP	_	_	_	0	_	Pred	_	_	_	_	_	EnglishA-wsj_1934-s8-t4	_
152	the	the	_	DT	_	_	_	154	_	AuxA	_	_	_	_	_	EnglishA-wsj_1934-s8-t5	(23
153	first	first	_	JJ	_	_	_	154	_	Atr	_	_	_	_	_	EnglishA-wsj_1934-s8-t6	_
154	humans	human	_	NNS	_	_	_	151	_	Pnom	_	_	_	_	_	EnglishA-wsj_1934-s8-t7	23)
155	to	to	_	TO	_	_	_	154	_	AuxP	_	_	_	_	_	EnglishA-wsj_1934-s8-t10	_
156	be	be	_	VB	_	_	_	157	_	AuxV	_	_	_	_	_	EnglishA-wsj_1934-s8-t11	_
157	given	give	_	VBN	_	_	_	155	_	Atr	_	_	_	_	_	EnglishA-wsj_1934-s8-t12	_
158	the	the	_	DT	_	_	_	159	_	AuxA	_	_	_	_	_	EnglishA-wsj_1934-s8-t14	(3
159	drug	drug	_	NN	_	_	_	157	_	Obj	_	_	_	_	_	EnglishA-wsj_1934-s8-t15	3)
160	,	,	_	,	_	_	_	159	_	AuxX	_	_	_	_	_	EnglishA-wsj_1934-s8-t16	_
161	which	which	_	WDT	_	_	_	163	_	Sb	_	_	_	_	_	EnglishA-wsj_1934-s8-t17	(3)
162	is	be	_	VBZ	_	_	_	163	_	AuxV	_	_	_	_	_	EnglishA-wsj_1934-s8-t19	_
163	made	make	_	VBN	_	_	_	159	_	Atr	_	_	_	_	_	EnglishA-wsj_1934-s8-t20	_
164	by	by	_	IN	_	_	_	163	_	AuxP	_	_	_	_	_	EnglishA-wsj_1934-s8-t22	_
165	Fujisawa	fujisawa	_	NNP	_	_	_	166	_	Atr	_	_	_	_	_	EnglishA-wsj_1934-s8-t23	(16
166	Pharmaceutical	pharmaceutical	_	NNP	_	_	_	167	_	Atr	_	_	_	_	_	EnglishA-wsj_1934-s8-t24	_
167	Co	co	_	NNP	_	_	_	164	_	Adv	_	_	_	_	_	EnglishA-wsj_1934-s8-t25	16)
168	.	.	_	.	_	_	_	151	_	AuxG	_	_	_	_	_	EnglishA-wsj_1934-s8-t26	_

169	``	``	_	``	_	_	_	184	_	AuxG	_	_	_	_	_	EnglishA-wsj_1934-s9-t1	_
170	We	we	_	PRP	_	_	_	172	_	NR	_	_	_	_	_	EnglishA-wsj_1934-s9-t2	(5)
171	're	be	_	VBP	_	_	_	172	_	NR	_	_	_	_	_	EnglishA-wsj_1934-s9-t3	_
172	shocked	shocked	_	JJ	_	_	_	184	_	Sb	_	_	_	_	_	EnglishA-wsj_1934-s9-t4	_
173	by	by	_	IN	_	_	_	172	_	AuxP	_	_	_	_	_	EnglishA-wsj_1934-s9-t5	_
174	it	it	_	PRP	_	_	_	173	_	Adv	_	_	_	_	_	EnglishA-wsj_1934-s9-t6	(3)
175	,	,	_	,	_	_	_	172	_	AuxX	_	_	_	_	_	EnglishA-wsj_1934-s9-t7	_
176	because	because	_	IN	_	_	_	172	_	AuxC	_	_	_	_	_	EnglishA-wsj_1934-s9-t8	_
177	it	it	_	PRP	_	_	_	179	_	Sb	_	_	_	_	_	EnglishA-wsj_1934-s9-t9	(3)
178	's	be	_	VBZ	_	_	_	179	_	AuxV	_	_	_	_	_	EnglishA-wsj_1934-s9-t10	_
179	worked	work	_	VBN	_	_	_	176	_	NR	_	_	_	_	_	EnglishA-wsj_1934-s9-t11	_
180	so	so	_	RB	_	_	_	181	_	Adv	_	_	_	_	_	EnglishA-wsj_1934-s9-t12	_
181	fast	fast	_	RB	_	_	_	179	_	Adv	_	_	_	_	_	EnglishA-wsj_1934-s9-t13	_
182	,	,	_	,	_	_	_	184	_	AuxX	_	_	_	_	_	EnglishA-wsj_1934-s9-t14	_
183	''	''	_	''	_	_	_	184	_	AuxG	_	_	_	_	_	EnglishA-wsj_1934-s9-t15	_
184	said	say	_	VBD	_	_	_	0	_	Pred	_	_	_	_	_	EnglishA-wsj_1934-s9-t16	_
185	Dr.	dr.	_	NNP	_	_	_	188	_	Atr	_	_	_	_	_	EnglishA-wsj_1934-s9-t18	(8
186	Thomas	Thomas	_	NNP	_	_	_	188	_	Atr	_	_	_	_	_	EnglishA-wsj_1934-s9-t19	_
187	E.	e.	_	NNP	_	_	_	188	_	Atr	_	_	_	_	_	EnglishA-wsj_1934-s9-t20	_
188	Starzl	starzl	_	NNP	_	_	_	189	_	Obj	_	_	_	_	_	EnglishA-wsj_1934-s9-t21	8)
189	,	,	_	,	_	_	_	184	_	Coord	_	_	_	_	_	EnglishA-wsj_1934-s9-t22	_
190	director	director	_	NN	_	_	_	189	_	Obj	_	_	_	_	_	EnglishA-wsj_1934-s9-t23	(8
191	of	of	_	IN	_	_	_	190	_	AuxP	_	_	_	_	_	EnglishA-wsj_1934-s9-t24	_
192	the	the	_	DT	_	_	_	197	_	AuxA	_	_	_	_	_	EnglishA-wsj_1934-s9-t25	(10
193	University	university	_	NNP	_	_	_	197	_	Atr	_	_	_	_	_	EnglishA-wsj_1934-s9-t26	_
194	of	of	_	IN	_	_	_	193	_	AuxP	_	_	_	_	_	EnglishA-wsj_1934-s9-t27	_
195	Pittsburgh	pittsburgh	_	NNP	_	_	_	194	_	Atr	_	_	_	_	_	EnglishA-wsj_1934-s9-t28	_
196	Transplantation	transplantation	_	NNP	_	_	_	197	_	Atr	_	_	_	_	_	EnglishA-wsj_1934-s9-t29	_
197	Program	program	_	NNP	_	_	_	191	_	Atr	_	_	_	_	_	EnglishA-wsj_1934-s9-t30	8)|10)
198	,	,	_	,	_	_	_	190	_	AuxX	_	_	_	_	_	EnglishA-wsj_1934-s9-t31	_
199	at	at	_	IN	_	_	_	184	_	AuxP	_	_	_	_	_	EnglishA-wsj_1934-s9-t32	_
200	a	a	_	DT	_	_	_	202	_	AuxA	_	_	_	_	_	EnglishA-wsj_1934-s9-t33	_
201	news	news	_	NN	_	_	_	202	_	Atr	_	_	_	_	_	EnglishA-wsj_1934-s9-t34	_
202	conference	conference	_	NN	_	_	_	199	_	Adv	_	_	_	_	_	EnglishA-wsj_1934-s9-t35	_
203	here	here	_	RB	_	_	_	184	_	Adv	_	_	_	_	_	EnglishA-wsj_1934-s9-t36	_
204	yesterday	yesterday	_	NN	_	_	_	184	_	Obj	_	_	_	_	_	EnglishA-wsj_1934-s9-t37	_
205	.	.	_	.	_	_	_	184	_	AuxG	_	_	_	_	_	EnglishA-wsj_1934-s9-t38	_

206	``	``	_	``	_	_	_	220	_	AuxG	_	_	_	_	_	EnglishA-wsj_1934-s10-t1	_
207	We	we	_	PRP	_	_	_	208	_	Sb	_	_	_	_	_	EnglishA-wsj_1934-s10-t2	(5)
208	consider	consider	_	VBP	_	_	_	220	_	Adv	_	_	_	_	_	EnglishA-wsj_1934-s10-t3	_
209	it	it	_	PRP	_	_	_	208	_	Obj	_	_	_	_	_	EnglishA-wsj_1934-s10-t4	(3)
210	a	a	_	DT	_	_	_	212	_	AuxA	_	_	_	_	_	EnglishA-wsj_1934-s10-t5	_
211	life-saving	life-saving	_	JJ	_	_	_	212	_	Atr	_	_	_	_	_	EnglishA-wsj_1934-s10-t6	_
212	drug	drug	_	NN	_	_	_	209	_	Atr	_	_	_	_	_	EnglishA-wsj_1934-s10-t7	_
213	,	,	_	,	_	_	_	212	_	AuxX	_	_	_	_	_	EnglishA-wsj_1934-s10-t8	_
214	like	like	_	IN	_	_	_	212	_	AuxP	_	_	_	_	_	EnglishA-wsj_1934-s10-t9	_
215	one	one	_	CD	_	_	_	214	_	Atr	_	_	_	_	_	EnglishA-wsj_1934-s10-t10	_
216	for	for	_	IN	_	_	_	215	_	AuxP	_	_	_	_	_	EnglishA-wsj_1934-s10-t11	_
217	AIDS	aid	_	NNP	_	_	_	216	_	Atr	_	_	_	_	_	EnglishA-wsj_1934-s10-t12	_
218	,	,	_	,	_	_	_	220	_	AuxX	_	_	_	_	_	EnglishA-wsj_1934-s10-t13	_
219	''	''	_	''	_	_	_	220	_	AuxG	_	_	_	_	_	EnglishA-wsj_1934-s10-t14	_
220	said	say	_	VBD	_	_	_	0	_	Pred	_	_	_	_	_	EnglishA-wsj_1934-s10-t15	_
221	Dr.	dr.	_	NNP	_	_	_	223	_	Atr	_	_	_	_	_	EnglishA-wsj_1934-s10-t17	(4
222	John	john	_	NNP	_	_	_	223	_	Atr	_	_	_	_	_	EnglishA-wsj_1934-s10-t18	_
223	Fung	fung	_	NNP	_	_	_	224	_	Sb	_	_	_	_	_	EnglishA-wsj_1934-s10-t19	4)
224	,	,	_	,	_	_	_	220	_	Coord	_	_	_	_	_	EnglishA-wsj_1934-s10-t20	_
225	an	an	_	DT	_	_	_	226	_	AuxA	_	_	_	_	_	EnglishA-wsj_1934-s10-t21	(4
226	immunologist	immunologist	_	NN	_	_	_	224	_	Obj	_	_	_	_	_	EnglishA-wsj_1934-s10-t22	_
227	at	at	_	IN	_	_	_	226	_	AuxP	_	_	_	_	_	EnglishA-wsj_1934-s10-t23	_
228	the	the	_	DT	_	_	_	229	_	AuxA	_	_	_	_	_	EnglishA-wsj_1934-s10-t24	(2
229	University	university	_	NNP	_	_	_	227	_	Atr	_	_	_	_	_	EnglishA-wsj_1934-s10-t25	_
230	of	of	_	IN	_	_	_	229	_	AuxP	_	_	_	_	_	EnglishA-wsj_1934-s10-t26	_
231	Pittsburgh	pittsburgh	_	NNP	_	_	_	230	_	Atr	_	_	_	_	_	EnglishA-wsj_1934-s10-t27	2)|4)
232	.	.	_	.	_	_	_	220	_	AuxG	_	_	_	_	_	EnglishA-wsj_1934-s10-t28	_

233	Researchers	researcher	_	NNS	_	_	_	234	_	Sb	_	_	_	_	_	EnglishA-wsj_1934-s11-t1	(6)
234	say	say	_	VBP	_	_	_	0	_	Pred	_	_	_	_	_	EnglishA-wsj_1934-s11-t2	_
235	they	they	_	PRP	_	_	_	236	_	Sb	_	_	_	_	_	EnglishA-wsj_1934-s11-t4	(6)
236	believe	believe	_	VBP	_	_	_	234	_	Adv	_	_	_	_	_	EnglishA-wsj_1934-s11-t5	_
237	FK-506	fk-506	_	NNP	_	_	_	238	_	Sb	_	_	_	_	_	EnglishA-wsj_1934-s11-t7	(3)
238	is	be	_	VBZ	_	_	_	236	_	Adv	_	_	_	_	_	EnglishA-wsj_1934-s11-t8	_
239	100	100	_	CD	_	_	_	242	_	NR	_	_	_	_	_	EnglishA-wsj_1934-s11-t9	_
240	times	time	_	NNS	_	_	_	239	_	Atr	_	_	_	_	_	EnglishA-wsj_1934-s11-t10	_
241	more	more	_	RBR	_	_	_	242	_	Adv	_	_	_	_	_	EnglishA-wsj_1934-s11-t11	_
242	effective	effective	_	JJ	_	_	_	238	_	Pnom	_	_	_	_	_	EnglishA-wsj_1934-s11-t12	_
243	than	than	_	IN	_	_	_	242	_	AuxP	_	_	_	_	_	EnglishA-wsj_1934-s11-t13	_
244	the	the	_	DT	_	_	_	247	_	AuxA	_	_	_	_	_	EnglishA-wsj_1934-s11-t14	(7|(7
245	traditional	traditional	_	JJ	_	_	_	247	_	Atr	_	_	_	_	_	EnglishA-wsj_1934-s11-t15	_
246	anti-rejection	anti-rejection	_	JJ	_	_	_	247	_	Atr	_	_	_	_	_	EnglishA-wsj_1934-s11-t16	_
247	drug	drug	_	NN	_	_	_	249	_	Atr	_	_	_	_	_	EnglishA-wsj_1934-s11-t17	7)
248	,	,	_	,	_	_	_	249	_	AuxX	_	_	_	_	_	EnglishA-wsj_1934-s11-t18	_
249	cyclosporine	cyclosporine	_	NN	_	_	_	243	_	Adv	_	_	_	_	_	EnglishA-wsj_1934-s11-t19	7)
250	,	,	_	,	_	_	_	249	_	AuxX	_	_	_	_	_	EnglishA-wsj_1934-s11-t20	_
251	made	make	_	VBN	_	_	_	249	_	Atr	_	_	_	_	_	EnglishA-wsj_1934-s11-t21	_
252	by	by	_	IN	_	_	_	251	_	AuxP	_	_	_	_	_	EnglishA-wsj_1934-s11-t23	_
253	Swiss	swiss	_	JJ	_	_	_	255	_	Atr	_	_	_	_	_	EnglishA-wsj_1934-s11-t24	_
254	pharmaceutical	pharmaceutical	_	JJ	_	_	_	255	_	Atr	_	_	_	_	_	EnglishA-wsj_1934-s11-t25	_
255	giant	giant	_	NN	_	_	_	257	_	Atr	_	_	_	_	_	EnglishA-wsj_1934-s11-t26	_
256	Sandoz	sandoz	_	NNP	_	_	_	257	_	Atr	_	_	_	_	_	EnglishA-wsj_1934-s11-t27	_
257	Ltd	ltd	_	NNP	_	_	_	252	_	Adv	_	_	_	_	_	EnglishA-wsj_1934-s11-t28	_
258	.	.	_	.	_	_	_	234	_	AuxG	_	_	_	_	_	EnglishA-wsj_1934-s11-t29	_

259	They	they	_	PRP	_	_	_	262	_	Sb	_	_	_	_	_	EnglishA-wsj_1934-s12-t1	(6)
260	are	be	_	VBP	_	_	_	262	_	AuxV	_	_	_	_	_	EnglishA-wsj_1934-s12-t2	_
261	also	also	_	RB	_	_	_	262	_	Adv	_	_	_	_	_	EnglishA-wsj_1934-s12-t3	_
262	encouraged	encourage	_	VBN	_	_	_	0	_	Pred	_	_	_	_	_	EnglishA-wsj_1934-s12-t4	_
263	by	by	_	IN	_	_	_	262	_	AuxP	_	_	_	_	_	EnglishA-wsj_1934-s12-t6	_
264	the	the	_	DT	_	_	_	268	_	AuxA	_	_	_	_	_	EnglishA-wsj_1934-s12-t7	_
265	relatively	relatively	_	RB	_	_	_	266	_	Adv	_	_	_	_	_	EnglishA-wsj_1934-s12-t8	_
266	mild	mild	_	JJ	_	_	_	268	_	Atr	_	_	_	_	_	EnglishA-wsj_1934-s12-t9	_
267	side	side	_	JJ	_	_	_	268	_	Atr	_	_	_	_	_	EnglishA-wsj_1934-s12-t10	_
268	effects	effect	_	NNS	_	_	_	263	_	Adv	_	_	_	_	_	EnglishA-wsj_1934-s12-t11	_
269	of	of	_	IN	_	_	_	268	_	AuxP	_	_	_	_	_	EnglishA-wsj_1934-s12-t12	_
270	FK-506	fk-506	_	NNP	_	_	_	269	_	Atr	_	_	_	_	_	EnglishA-wsj_1934-s12-t13	(3)
271	,	,	_	,	_	_	_	268	_	AuxX	_	_	_	_	_	EnglishA-wsj_1934-s12-t14	_
272	compared	compare	_	VBN	_	_	_	268	_	Atr	_	_	_	_	_	EnglishA-wsj_1934-s12-t15	(7
273	with	with	_	IN	_	_	_	272	_	AuxP	_	_	_	_	_	EnglishA-wsj_1934-s12-t16	_
274	cyclosporine	cyclosporine	_	NN	_	_	_	273	_	Adv	_	_	_	_	_	EnglishA-wsj_1934-s12-t17	7)
275	,	,	_	,	_	_	_	274	_	AuxX	_	_	_	_	_	EnglishA-wsj_1934-s12-t18	_
276	which	which	_	WDT	_	_	_	277	_	Sb	_	_	_	_	_	EnglishA-wsj_1934-s12-t19	(7)
277	can	can	_	MD	_	_	_	274	_	Atr	_	_	_	_	_	EnglishA-wsj_1934-s12-t21	_
278	cause	cause	_	VB	_	_	_	277	_	Obj	_	_	_	_	_	EnglishA-wsj_1934-s12-t22	_
279	renal	renal	_	JJ	_	_	_	280	_	Atr	_	_	_	_	_	EnglishA-wsj_1934-s12-t23	_
280	failure	failure	_	NN	_	_	_	285	_	Obj	_	_	_	_	_	EnglishA-wsj_1934-s12-t24	_
281	,	,	_	,	_	_	_	285	_	AuxX	_	_	_	_	_	EnglishA-wsj_1934-s12-t25	_
282	morbidity	morbidity	_	NN	_	_	_	285	_	Obj	_	_	_	_	_	EnglishA-wsj_1934-s12-t26	_
283	,	,	_	,	_	_	_	285	_	AuxX	_	_	_	_	_	EnglishA-wsj_1934-s12-t27	_
284	nausea	nausea	_	NN	_	_	_	285	_	Obj	_	_	_	_	_	EnglishA-wsj_1934-s12-t28	_
285	and	and	_	CC	_	_	_	278	_	Coord	_	_	_	_	_	EnglishA-wsj_1934-s12-t29	_
286	other	other	_	JJ	_	_	_	287	_	Atr	_	_	_	_	_	EnglishA-wsj_1934-s12-t30	_
287	problems	problem	_	NNS	_	_	_	285	_	Obj	_	_	_	_	_	EnglishA-wsj_1934-s12-t31	_
288	.	.	_	.	_	_	_	262	_	AuxG	_	_	_	_	_	EnglishA-wsj_1934-s12-t32	_

289	``	``	_	``	_	_	_	310	_	AuxG	_	_	_	_	_	EnglishA-wsj_1934-s13-t1	_
290	The	the	_	DT	_	_	_	292	_	AuxA	_	_	_	_	_	EnglishA-wsj_1934-s13-t2	_
291	side	side	_	JJ	_	_	_	292	_	Atr	_	_	_	_	_	EnglishA-wsj_1934-s13-t3	_
292	effects	effect	_	NNS	_	_	_	298	_	Sb	_	_	_	_	_	EnglishA-wsj_1934-s13-t4	_
293	-LCB-	-lcb-	_	-LRB-	_	_	_	292	_	NR	_	_	_	_	_	EnglishA-wsj_1934-s13-t5	_
294	of	of	_	IN	_	_	_	293	_	AuxP	_	_	_	_	_	EnglishA-wsj_1934-s13-t6	_
295	cyclosporine	cyclosporine	_	NN	_	_	_	294	_	Adv	_	_	_	_	_	EnglishA-wsj_1934-s13-t7	(7)
296	-RCB-	-rcb-	_	-RRB-	_	_	_	293	_	NR	_	_	_	_	_	EnglishA-wsj_1934-s13-t8	_
297	have	have	_	VBP	_	_	_	298	_	AuxV	_	_	_	_	_	EnglishA-wsj_1934-s13-t9	_
298	made	make	_	VBN	_	_	_	310	_	Adv	_	_	_	_	_	EnglishA-wsj_1934-s13-t10	_
299	the	the	_	DT	_	_	_	300	_	AuxA	_	_	_	_	_	EnglishA-wsj_1934-s13-t11	_
300	penalty	penalty	_	NN	_	_	_	298	_	Obj	_	_	_	_	_	EnglishA-wsj_1934-s13-t12	_
301	for	for	_	IN	_	_	_	300	_	AuxP	_	_	_	_	_	EnglishA-wsj_1934-s13-t13	_
302	its	its	_	PRP$	_	_	_	303	_	Atr	_	_	_	_	_	EnglishA-wsj_1934-s13-t14	(7)
303	success	success	_	NN	_	_	_	301	_	Atr	_	_	_	_	_	EnglishA-wsj_1934-s13-t15	_
304	rather	rather	_	RB	_	_	_	305	_	Adv	_	_	_	_	_	EnglishA-wsj_1934-s13-t16	_
305	high	high	_	JJ	_	_	_	300	_	Atr	_	_	_	_	_	EnglishA-wsj_1934-s13-t17	_
306	,	,	_	,	_	_	_	310	_	AuxX	_	_	_	_	_	EnglishA-wsj_1934-s13-t18	_
307	''	''	_	''	_	_	_	310	_	AuxG	_	_	_	_	_	EnglishA-wsj_1934-s13-t19	_
308	Dr.	dr.	_	NNP	_	_	_	309	_	Atr	_	_	_	_	_	EnglishA-wsj_1934-s13-t20	(8
309	Starzl	starzl	_	NNP	_	_	_	310	_	Sb	_	_	_	_	_	EnglishA-wsj_1934-s13-t21	8)
310	said	say	_	VBD	_	_	_	0	_	Pred	_	_	_	_	_	EnglishA-wsj_1934-s13-t22	_
311	.	.	_	.	_	_	_	310	_	AuxG	_	_	_	_	_	EnglishA-wsj_1934-s13-t24	_

312	Dr.	dr.	_	NNP	_	_	_	313	_	Atr	_	_	_	_	_	EnglishA-wsj_1934-s14-t1	(4
313	Fung	fung	_	NNP	_	_	_	314	_	Sb	_	_	_	_	_	EnglishA-wsj_1934-s14-t2	4)
314	said	say	_	VBD	_	_	_	0	_	Pred	_	_	_	_	_	EnglishA-wsj_1934-s14-t3	_
315	that	that	_	IN	_	_	_	330	_	AuxP	_	_	_	_	_	EnglishA-wsj_1934-s14-t4	_
316	FK-506	fk-506	_	NNP	_	_	_	317	_	Sb	_	_	_	_	_	EnglishA-wsj_1934-s14-t5	(3)
317	would	would	_	MD	_	_	_	315	_	NR	_	_	_	_	_	EnglishA-wsj_1934-s14-t6	_
318	not	not	_	RB	_	_	_	317	_	Neg	_	_	_	_	_	EnglishA-wsj_1934-s14-t7	_
319	be	be	_	VB	_	_	_	317	_	Obj	_	_	_	_	_	EnglishA-wsj_1934-s14-t8	_
320	available	available	_	JJ	_	_	_	319	_	Pnom	_	_	_	_	_	EnglishA-wsj_1934-s14-t9	_
321	in	in	_	IN	_	_	_	319	_	AuxP	_	_	_	_	_	EnglishA-wsj_1934-s14-t10	_
322	the	the	_	DT	_	_	_	323	_	AuxA	_	_	_	_	_	EnglishA-wsj_1934-s14-t11	_
323	market	market	_	NN	_	_	_	321	_	Adv	_	_	_	_	_	EnglishA-wsj_1934-s14-t12	_
324	for	for	_	IN	_	_	_	319	_	AuxP	_	_	_	_	_	EnglishA-wsj_1934-s14-t13	_
325	at	at	_	IN	_	_	_	328	_	AuxP	_	_	_	_	_	EnglishA-wsj_1934-s14-t14	_
326	least	least	_	JJS	_	_	_	325	_	NR	_	_	_	_	_	EnglishA-wsj_1934-s14-t15	_
327	a	a	_	DT	_	_	_	325	_	AuxA	_	_	_	_	_	EnglishA-wsj_1934-s14-t16	_
328	year	year	_	NN	_	_	_	324	_	Adv	_	_	_	_	_	EnglishA-wsj_1934-s14-t17	_
329	,	,	_	,	_	_	_	330	_	AuxX	_	_	_	_	_	EnglishA-wsj_1934-s14-t18	_
330	and	and	_	CC	_	_	_	314	_	Coord	_	_	_	_	_	EnglishA-wsj_1934-s14-t19	_
331	that	that	_	IN	_	_	_	330	_	AuxC	_	_	_	_	_	EnglishA-wsj_1934-s14-t20	_
332	the	the	_	DT	_	_	_	335	_	AuxA	_	_	_	_	_	EnglishA-wsj_1934-s14-t21	_
333	FDA	fda	_	NNP	_	_	_	334	_	Atr	_	_	_	_	_	EnglishA-wsj_1934-s14-t22	(9)
334	approval	approval	_	NN	_	_	_	335	_	Atr	_	_	_	_	_	EnglishA-wsj_1934-s14-t23	_
335	process	process	_	NN	_	_	_	337	_	Sb	_	_	_	_	_	EnglishA-wsj_1934-s14-t24	_
336	usually	usually	_	RB	_	_	_	337	_	Adv	_	_	_	_	_	EnglishA-wsj_1934-s14-t25	_
337	takes	take	_	VBZ	_	_	_	331	_	NR	_	_	_	_	_	EnglishA-wsj_1934-s14-t26	_
338	three	three	_	CD	_	_	_	339	_	Atr	_	_	_	_	_	EnglishA-wsj_1934-s14-t27	_
339	years	year	_	NNS	_	_	_	340	_	Adv	_	_	_	_	_	EnglishA-wsj_1934-s14-t28	_
340	to	to	_	TO	_	_	_	337	_	AuxP	_	_	_	_	_	EnglishA-wsj_1934-s14-t29	_
341	five	five	_	CD	_	_	_	342	_	Atr	_	_	_	_	_	EnglishA-wsj_1934-s14-t30	_
342	years	year	_	NNS	_	_	_	340	_	Adv	_	_	_	_	_	EnglishA-wsj_1934-s14-t31	_
343	.	.	_	.	_	_	_	314	_	AuxG	_	_	_	_	_	EnglishA-wsj_1934-s14-t32	_

344	There	there	_	EX	_	_	_	345	_	Sb	_	_	_	_	_	EnglishA-wsj_1934-s15-t1	_
345	are	be	_	VBP	_	_	_	0	_	Pred	_	_	_	_	_	EnglishA-wsj_1934-s15-t2	_
346	no	no	_	DT	_	_	_	348	_	Atr	_	_	_	_	_	EnglishA-wsj_1934-s15-t3	_
347	firm	firm	_	JJ	_	_	_	348	_	Atr	_	_	_	_	_	EnglishA-wsj_1934-s15-t4	_
348	plans	plan	_	NNS	_	_	_	345	_	Pnom	_	_	_	_	_	EnglishA-wsj_1934-s15-t5	_
349	to	to	_	TO	_	_	_	348	_	AuxP	_	_	_	_	_	EnglishA-wsj_1934-s15-t7	_
350	expand	expand	_	VB	_	_	_	349	_	Atr	_	_	_	_	_	EnglishA-wsj_1934-s15-t8	_
351	the	the	_	DT	_	_	_	353	_	AuxA	_	_	_	_	_	EnglishA-wsj_1934-s15-t9	(10
352	experimental	experimental	_	JJ	_	_	_	353	_	Atr	_	_	_	_	_	EnglishA-wsj_1934-s15-t10	_
353	program	program	_	NN	_	_	_	350	_	Obj	_	_	_	_	_	EnglishA-wsj_1934-s15-t11	10)
354	beyond	beyond	_	IN	_	_	_	350	_	AuxP	_	_	_	_	_	EnglishA-wsj_1934-s15-t12	_
355	the	the	_	DT	_	_	_	356	_	AuxA	_	_	_	_	_	EnglishA-wsj_1934-s15-t13	(2
356	University	university	_	NNP	_	_	_	354	_	Adv	_	_	_	_	_	EnglishA-wsj_1934-s15-t14	_
357	of	of	_	IN	_	_	_	356	_	AuxP	_	_	_	_	_	EnglishA-wsj_1934-s15-t15	_
358	Pittsburgh	pittsburgh	_	NNP	_	_	_	357	_	Atr	_	_	_	_	_	EnglishA-wsj_1934-s15-t16	2)
359	,	,	_	,	_	_	_	356	_	AuxX	_	_	_	_	_	EnglishA-wsj_1934-s15-t17	_
360	whose	whose	_	WP$	_	_	_	362	_	Sb	_	_	_	_	_	EnglishA-wsj_1934-s15-t18	(2)|(11
361	hospital	hospital	_	NN	_	_	_	360	_	Atr	_	_	_	_	_	EnglishA-wsj_1934-s15-t19	11)
362	performs	perform	_	VBZ	_	_	_	356	_	Atr	_	_	_	_	_	EnglishA-wsj_1934-s15-t21	_
363	the	the	_	DT	_	_	_	365	_	AuxA	_	_	_	_	_	EnglishA-wsj_1934-s15-t22	_
364	most	most	_	JJS	_	_	_	365	_	Atr	_	_	_	_	_	EnglishA-wsj_1934-s15-t23	_
365	transplants	transplant	_	NNS	_	_	_	362	_	Obj	_	_	_	_	_	EnglishA-wsj_1934-s15-t24	_
366	in	in	_	IN	_	_	_	365	_	AuxP	_	_	_	_	_	EnglishA-wsj_1934-s15-t25	_
367	the	the	_	DT	_	_	_	368	_	AuxA	_	_	_	_	_	EnglishA-wsj_1934-s15-t26	_
368	world	world	_	NN	_	_	_	366	_	Atr	_	_	_	_	_	EnglishA-wsj_1934-s15-t27	_
369	.	.	_	.	_	_	_	345	_	AuxG	_	_	_	_	_	EnglishA-wsj_1934-s15-t28	_

370	Researchers	researcher	_	NNS	_	_	_	371	_	Sb	_	_	_	_	_	EnglishA-wsj_1934-s16-t1	(13)
371	could	could	_	MD	_	_	_	385	_	Pred	_	_	_	_	_	EnglishA-wsj_1934-s16-t2	_
372	n't	n't	_	RB	_	_	_	371	_	Adv	_	_	_	_	_	EnglishA-wsj_1934-s16-t3	_
373	estimate	estimate	_	VB	_	_	_	371	_	Obj	_	_	_	_	_	EnglishA-wsj_1934-s16-t4	_
374	the	the	_	DT	_	_	_	375	_	AuxA	_	_	_	_	_	EnglishA-wsj_1934-s16-t5	_
375	cost	cost	_	NN	_	_	_	373	_	Obj	_	_	_	_	_	EnglishA-wsj_1934-s16-t6	_
376	of	of	_	IN	_	_	_	375	_	AuxP	_	_	_	_	_	EnglishA-wsj_1934-s16-t7	_
377	the	the	_	DT	_	_	_	378	_	AuxA	_	_	_	_	_	EnglishA-wsj_1934-s16-t8	(3
378	drug	drug	_	NN	_	_	_	376	_	Atr	_	_	_	_	_	EnglishA-wsj_1934-s16-t9	3)
379	when	when	_	WRB	_	_	_	381	_	NR	_	_	_	_	_	EnglishA-wsj_1934-s16-t10	_
380	it	it	_	PRP	_	_	_	381	_	Sb	_	_	_	_	_	EnglishA-wsj_1934-s16-t11	(3)
381	reaches	reach	_	VBZ	_	_	_	375	_	Atr	_	_	_	_	_	EnglishA-wsj_1934-s16-t12	_
382	the	the	_	DT	_	_	_	383	_	AuxA	_	_	_	_	_	EnglishA-wsj_1934-s16-t13	_
383	market	market	_	NN	_	_	_	381	_	Obj	_	_	_	_	_	EnglishA-wsj_1934-s16-t14	_
384	,	,	_	,	_	_	_	385	_	ExD	_	_	_	_	_	EnglishA-wsj_1934-s16-t16	_
385	but	but	_	CC	_	_	_	0	_	Coord	_	_	_	_	_	EnglishA-wsj_1934-s16-t17	_
386	they	they	_	PRP	_	_	_	387	_	Sb	_	_	_	_	_	EnglishA-wsj_1934-s16-t18	(13)
387	said	say	_	VBD	_	_	_	385	_	Pred	_	_	_	_	_	EnglishA-wsj_1934-s16-t19	_
388	FK-506	fk-506	_	NNP	_	_	_	399	_	Sb	_	_	_	_	_	EnglishA-wsj_1934-s16-t21	(3)
389	will	will	_	MD	_	_	_	399	_	AuxV	_	_	_	_	_	EnglishA-wsj_1934-s16-t22	_
390	enable	enable	_	VB	_	_	_	399	_	Adv	_	_	_	_	_	EnglishA-wsj_1934-s16-t23	_
391	patients	patient	_	NNS	_	_	_	392	_	Adv	_	_	_	_	_	EnglishA-wsj_1934-s16-t24	(14)
392	to	to	_	TO	_	_	_	390	_	AuxP	_	_	_	_	_	EnglishA-wsj_1934-s16-t25	_
393	cut	cut	_	VB	_	_	_	392	_	Adv	_	_	_	_	_	EnglishA-wsj_1934-s16-t26	_
394	hospital	hospital	_	NN	_	_	_	395	_	Atr	_	_	_	_	_	EnglishA-wsj_1934-s16-t27	_
395	stays	stay	_	NNS	_	_	_	393	_	Obj	_	_	_	_	_	EnglishA-wsj_1934-s16-t28	_
396	by	by	_	IN	_	_	_	393	_	AuxP	_	_	_	_	_	EnglishA-wsj_1934-s16-t29	_
397	50	50	_	CD	_	_	_	398	_	Atr	_	_	_	_	_	EnglishA-wsj_1934-s16-t30	_
398	%	%	_	NN	_	_	_	396	_	Adv	_	_	_	_	_	EnglishA-wsj_1934-s16-t31	_
399	and	and	_	CC	_	_	_	387	_	Coord	_	_	_	_	_	EnglishA-wsj_1934-s16-t32	_
400	reduce	reduce	_	VB	_	_	_	399	_	Adv	_	_	_	_	_	EnglishA-wsj_1934-s16-t33	_
401	the	the	_	DT	_	_	_	402	_	AuxA	_	_	_	_	_	EnglishA-wsj_1934-s16-t34	_
402	number	number	_	NN	_	_	_	400	_	Obj	_	_	_	_	_	EnglishA-wsj_1934-s16-t35	_
403	of	of	_	IN	_	_	_	402	_	AuxP	_	_	_	_	_	EnglishA-wsj_1934-s16-t36	_
404	blood	blood	_	NN	_	_	_	405	_	Atr	_	_	_	_	_	EnglishA-wsj_1934-s16-t37	(15
405	tests	test	_	NNS	_	_	_	403	_	Atr	_	_	_	_	_	EnglishA-wsj_1934-s16-t38	15)
406	used	use	_	VBN	_	_	_	405	_	Atr	_	_	_	_	_	EnglishA-wsj_1934-s16-t39	_
407	to	to	_	TO	_	_	_	406	_	AuxP	_	_	_	_	_	EnglishA-wsj_1934-s16-t41	_
408	monitor	monitor	_	VB	_	_	_	407	_	Adv	_	_	_	_	_	EnglishA-wsj_1934-s16-t42	_
409	the	the	_	DT	_	_	_	410	_	AuxA	_	_	_	_	_	EnglishA-wsj_1934-s16-t43	_
410	dosage	dosage	_	NN	_	_	_	408	_	Obj	_	_	_	_	_	EnglishA-wsj_1934-s16-t44	_
411	of	of	_	IN	_	_	_	410	_	AuxP	_	_	_	_	_	EnglishA-wsj_1934-s16-t45	_
412	cyclosporine	cyclosporine	_	JJ	_	_	_	413	_	NR	_	_	_	_	_	EnglishA-wsj_1934-s16-t46	(7)
413	and	and	_	CC	_	_	_	411	_	Coord	_	_	_	_	_	EnglishA-wsj_1934-s16-t47	_
414	other	other	_	JJ	_	_	_	415	_	Atr	_	_	_	_	_	EnglishA-wsj_1934-s16-t48	(3
415	drugs	drug	_	NNS	_	_	_	413	_	Atr	_	_	_	_	_	EnglishA-wsj_1934-s16-t49	3)
416	among	among	_	IN	_	_	_	406	_	AuxP	_	_	_	_	_	EnglishA-wsj_1934-s16-t50	_
417	transplant	transplant	_	NN	_	_	_	418	_	Atr	_	_	_	_	_	EnglishA-wsj_1934-s16-t51	_
418	recipients	recipient	_	NNS	_	_	_	416	_	Adv	_	_	_	_	_	EnglishA-wsj_1934-s16-t52	_
419	.	.	_	.	_	_	_	385	_	AuxG	_	_	_	_	_	EnglishA-wsj_1934-s16-t53	_

420	Dr.	dr.	_	NNP	_	_	_	421	_	Atr	_	_	_	_	_	EnglishA-wsj_1934-s17-t1	(8
421	Starzl	starzl	_	NNP	_	_	_	422	_	Sb	_	_	_	_	_	EnglishA-wsj_1934-s17-t2	8)
422	said	say	_	VBD	_	_	_	0	_	Pred	_	_	_	_	_	EnglishA-wsj_1934-s17-t3	_
423	the	the	_	DT	_	_	_	424	_	AuxA	_	_	_	_	_	EnglishA-wsj_1934-s17-t5	(17
424	research	research	_	NN	_	_	_	428	_	Sb	_	_	_	_	_	EnglishA-wsj_1934-s17-t6	17)
425	has	have	_	VBZ	_	_	_	428	_	AuxV	_	_	_	_	_	EnglishA-wsj_1934-s17-t7	_
426	been	be	_	VBN	_	_	_	428	_	AuxV	_	_	_	_	_	EnglishA-wsj_1934-s17-t8	_
427	largely	largely	_	RB	_	_	_	428	_	Adv	_	_	_	_	_	EnglishA-wsj_1934-s17-t9	_
428	financed	finance	_	VBN	_	_	_	440	_	Adv	_	_	_	_	_	EnglishA-wsj_1934-s17-t10	_
429	by	by	_	IN	_	_	_	435	_	AuxP	_	_	_	_	_	EnglishA-wsj_1934-s17-t12	_
430	the	the	_	DT	_	_	_	432	_	AuxA	_	_	_	_	_	EnglishA-wsj_1934-s17-t13	_
431	National	national	_	NNP	_	_	_	432	_	Atr	_	_	_	_	_	EnglishA-wsj_1934-s17-t14	_
432	Institute	institute	_	NNP	_	_	_	429	_	Adv	_	_	_	_	_	EnglishA-wsj_1934-s17-t15	_
433	of	of	_	IN	_	_	_	432	_	AuxP	_	_	_	_	_	EnglishA-wsj_1934-s17-t16	_
434	Health	health	_	NNP	_	_	_	433	_	Atr	_	_	_	_	_	EnglishA-wsj_1934-s17-t17	_
435	and	and	_	CC	_	_	_	428	_	Coord	_	_	_	_	_	EnglishA-wsj_1934-s17-t18	_
436	by	by	_	IN	_	_	_	435	_	AuxP	_	_	_	_	_	EnglishA-wsj_1934-s17-t19	_
437	university	university	_	NN	_	_	_	438	_	Atr	_	_	_	_	_	EnglishA-wsj_1934-s17-t20	(2)
438	funds	fund	_	NNS	_	_	_	436	_	Adv	_	_	_	_	_	EnglishA-wsj_1934-s17-t21	_
439	,	,	_	,	_	_	_	440	_	AuxX	_	_	_	_	_	EnglishA-wsj_1934-s17-t22	_
440	and	and	_	CC	_	_	_	422	_	Coord	_	_	_	_	_	EnglishA-wsj_1934-s17-t23	_
441	that	that	_	IN	_	_	_	440	_	AuxC	_	_	_	_	_	EnglishA-wsj_1934-s17-t24	_
442	Fujisawa	fujisawa	_	NNP	_	_	_	445	_	Sb	_	_	_	_	_	EnglishA-wsj_1934-s17-t25	(16)
443	did	do	_	VBD	_	_	_	445	_	AuxV	_	_	_	_	_	EnglishA-wsj_1934-s17-t26	_
444	n't	n't	_	RB	_	_	_	445	_	Adv	_	_	_	_	_	EnglishA-wsj_1934-s17-t27	_
445	give	give	_	VB	_	_	_	441	_	NR	_	_	_	_	_	EnglishA-wsj_1934-s17-t28	_
446	the	the	_	DT	_	_	_	447	_	AuxA	_	_	_	_	_	EnglishA-wsj_1934-s17-t29	(11
447	hospital	hospital	_	NN	_	_	_	445	_	Obj	_	_	_	_	_	EnglishA-wsj_1934-s17-t30	11)
448	any	any	_	DT	_	_	_	449	_	Atr	_	_	_	_	_	EnglishA-wsj_1934-s17-t31	_
449	grants	grant	_	NNS	_	_	_	445	_	Obj	_	_	_	_	_	EnglishA-wsj_1934-s17-t32	_
450	.	.	_	.	_	_	_	422	_	AuxG	_	_	_	_	_	EnglishA-wsj_1934-s17-t33	_

451	He	he	_	PRP	_	_	_	452	_	Sb	_	_	_	_	_	EnglishA-wsj_1934-s18-t1	(8)
452	said	say	_	VBD	_	_	_	0	_	Pred	_	_	_	_	_	EnglishA-wsj_1934-s18-t2	_
453	that	that	_	IN	_	_	_	452	_	AuxC	_	_	_	_	_	EnglishA-wsj_1934-s18-t3	_
454	the	the	_	DT	_	_	_	456	_	AuxA	_	_	_	_	_	EnglishA-wsj_1934-s18-t4	(13
455	research	research	_	NN	_	_	_	456	_	Atr	_	_	_	_	_	EnglishA-wsj_1934-s18-t5	(17)
456	team	team	_	NN	_	_	_	457	_	Sb	_	_	_	_	_	EnglishA-wsj_1934-s18-t6	13)
457	had	have	_	VBD	_	_	_	453	_	Adv	_	_	_	_	_	EnglishA-wsj_1934-s18-t7	_
458	no	no	_	DT	_	_	_	460	_	Atr	_	_	_	_	_	EnglishA-wsj_1934-s18-t8	_
459	financial	financial	_	JJ	_	_	_	460	_	Atr	_	_	_	_	_	EnglishA-wsj_1934-s18-t9	_
460	stake	stake	_	NN	_	_	_	457	_	Obj	_	_	_	_	_	EnglishA-wsj_1934-s18-t10	_
461	in	in	_	IN	_	_	_	460	_	AuxP	_	_	_	_	_	EnglishA-wsj_1934-s18-t11	_
462	the	the	_	DT	_	_	_	463	_	AuxA	_	_	_	_	_	EnglishA-wsj_1934-s18-t12	(3
463	drug	drug	_	NN	_	_	_	461	_	Atr	_	_	_	_	_	EnglishA-wsj_1934-s18-t13	3)
464	.	.	_	.	_	_	_	452	_	AuxG	_	_	_	_	_	EnglishA-wsj_1934-s18-t14	_

465	``	``	_	``	_	_	_	497	_	AuxG	_	_	_	_	_	EnglishA-wsj_1934-s19-t1	_
466	We	we	_	PRP	_	_	_	468	_	Sb	_	_	_	_	_	EnglishA-wsj_1934-s19-t2	(13)
467	've	have	_	VBP	_	_	_	468	_	AuxV	_	_	_	_	_	EnglishA-wsj_1934-s19-t3	_
468	known	know	_	VBN	_	_	_	478	_	Adv	_	_	_	_	_	EnglishA-wsj_1934-s19-t4	_
469	for	for	_	IN	_	_	_	468	_	AuxP	_	_	_	_	_	EnglishA-wsj_1934-s19-t5	_
470	six	six	_	CD	_	_	_	471	_	Atr	_	_	_	_	_	EnglishA-wsj_1934-s19-t6	_
471	months	month	_	NNS	_	_	_	469	_	Adv	_	_	_	_	_	EnglishA-wsj_1934-s19-t7	_
472	the	the	_	DT	_	_	_	473	_	AuxA	_	_	_	_	_	EnglishA-wsj_1934-s19-t8	_
473	effect	effect	_	NN	_	_	_	468	_	Obj	_	_	_	_	_	EnglishA-wsj_1934-s19-t9	_
474	of	of	_	IN	_	_	_	473	_	AuxP	_	_	_	_	_	EnglishA-wsj_1934-s19-t10	_
475	this	this	_	DT	_	_	_	476	_	Atr	_	_	_	_	_	EnglishA-wsj_1934-s19-t11	(3
476	drug	drug	_	NN	_	_	_	474	_	Atr	_	_	_	_	_	EnglishA-wsj_1934-s19-t12	3)
477	,	,	_	,	_	_	_	478	_	AuxX	_	_	_	_	_	EnglishA-wsj_1934-s19-t13	_
478	and	and	_	CC	_	_	_	497	_	Coord	_	_	_	_	_	EnglishA-wsj_1934-s19-t14	_
479	our	our	_	PRP$	_	_	_	480	_	Atr	_	_	_	_	_	EnglishA-wsj_1934-s19-t15	(13)
480	advice	advice	_	NN	_	_	_	485	_	Sb	_	_	_	_	_	EnglishA-wsj_1934-s19-t16	_
481	to	to	_	TO	_	_	_	480	_	AuxP	_	_	_	_	_	EnglishA-wsj_1934-s19-t17	(18
482	our	our	_	PRP$	_	_	_	483	_	Atr	_	_	_	_	_	EnglishA-wsj_1934-s19-t18	(13)
483	people	people	_	NNS	_	_	_	481	_	Atr	_	_	_	_	_	EnglishA-wsj_1934-s19-t19	18)
484	has	have	_	VBZ	_	_	_	485	_	AuxV	_	_	_	_	_	EnglishA-wsj_1934-s19-t20	_
485	been	be	_	VBN	_	_	_	478	_	Adv	_	_	_	_	_	EnglishA-wsj_1934-s19-t21	_
486	not	not	_	RB	_	_	_	487	_	Neg	_	_	_	_	_	EnglishA-wsj_1934-s19-t23	_
487	to	to	_	TO	_	_	_	485	_	AuxP	_	_	_	_	_	EnglishA-wsj_1934-s19-t24	_
488	buy	buy	_	VB	_	_	_	487	_	Adv	_	_	_	_	_	EnglishA-wsj_1934-s19-t25	_
489	the	the	_	DT	_	_	_	490	_	AuxA	_	_	_	_	_	EnglishA-wsj_1934-s19-t26	(16
490	company	company	_	NN	_	_	_	492	_	Atr	_	_	_	_	_	EnglishA-wsj_1934-s19-t27	_
491	's	's	_	POS	_	_	_	490	_	Atr	_	_	_	_	_	EnglishA-wsj_1934-s19-t28	16)
492	stock	stock	_	NN	_	_	_	488	_	Obj	_	_	_	_	_	EnglishA-wsj_1934-s19-t29	_
493	,	,	_	,	_	_	_	497	_	AuxX	_	_	_	_	_	EnglishA-wsj_1934-s19-t30	_
494	''	''	_	''	_	_	_	497	_	AuxG	_	_	_	_	_	EnglishA-wsj_1934-s19-t31	_
495	Dr.	dr.	_	NNP	_	_	_	496	_	Atr	_	_	_	_	_	EnglishA-wsj_1934-s19-t32	(8
496	Starzl	starzl	_	NNP	_	_	_	497	_	Sb	_	_	_	_	_	EnglishA-wsj_1934-s19-t33	8)
497	said	say	_	VBD	_	_	_	0	_	Pred	_	_	_	_	_	EnglishA-wsj_1934-s19-t34	_
498	,	,	_	,	_	_	_	497	_	AuxX	_	_	_	_	_	EnglishA-wsj_1934-s19-t36	_
499	adding	add	_	VBG	_	_	_	497	_	Adv	_	_	_	_	_	EnglishA-wsj_1934-s19-t38	_
500	that	that	_	IN	_	_	_	499	_	AuxP	_	_	_	_	_	EnglishA-wsj_1934-s19-t39	_
501	profiting	profit	_	VBG	_	_	_	504	_	Obj	_	_	_	_	_	EnglishA-wsj_1934-s19-t41	_
502	from	from	_	IN	_	_	_	501	_	AuxP	_	_	_	_	_	EnglishA-wsj_1934-s19-t42	_
503	FK-506	fk-506	_	NNP	_	_	_	502	_	Adv	_	_	_	_	_	EnglishA-wsj_1934-s19-t43	(3)
504	would	would	_	MD	_	_	_	500	_	Adv	_	_	_	_	_	EnglishA-wsj_1934-s19-t44	_
505	n't	n't	_	RB	_	_	_	504	_	Adv	_	_	_	_	_	EnglishA-wsj_1934-s19-t45	_
506	be	be	_	VB	_	_	_	504	_	Obj	_	_	_	_	_	EnglishA-wsj_1934-s19-t46	_
507	ethical	ethical	_	JJ	_	_	_	506	_	Pnom	_	_	_	_	_	EnglishA-wsj_1934-s19-t47	_
508	.	.	_	.	_	_	_	497	_	AuxG	_	_	_	_	_	EnglishA-wsj_1934-s19-t48	_

#end document wsj_1934
